Challenging Biology can we code human cells for health

[Music]

hi

my name is mark i’m a neurosurgeon and a

sensor biologist

and over the past 10 years i’ve become

an entrepreneur

i’d like to start telling you about my

work as a neurosurgeon

my focus are spinal cord injuries when

someone breaks

their neck in a car accident there’s a

high likelihood

that their spinal cord is damaged the

trauma disrupts the neural tissue

nerve cells and their connections are

lost

as well as the surrounding support cells

this can result in immediate paralysis

and loss of neurological function

as a neurosurgeon i’m called after the

patient arrives in the emergency room

and the injury is confirmed on imaging

my job is to manage

the next steps

many of my patients require urgent

surgery

i use state-of-the-art navigation

systems to place screws like this one

into the bony structures surrounding the

spinal cord

this stabilizes the spine but it doesn’t

repair the neurological injury

the spinal cord is unable to regenerate

the nerve cells that were lost

in the injury and their connections

most of my patients therefore remain

paralyzed

unable to use their hands or walk

and some of them are even unable to

breathe on their own

in fact i realize that many of the

conditions that i face

as neurosurgeon whether they are cancers

genetic or degenerative conditions

require more than a scalpel and screws

and they can’t be treated successfully

with conventional drugs either

because they require the regeneration of

lost cells

what we need is a revolution in medicine

a new set of sophisticated interventions

that

that can help these most difficult

medical problems

we need to move from small molecules and

biologics

to a new generation of intelligent

therapies

drugs that can interact with their

environment in other words

cell therapies the good news is that

this revolution is already on its way

the first cell therapies have been

approved

genetically engineered immune cells are

starting to transform the treatment of

cancer

as you can see on this video these

so-called car t cells

are able to identify tumor cells and

kill them

a meta study investigating 27 cd19 car t

cell therapy studies showed that 54.4

percent of patients experienced a

complete

response of their blood cancer

car t’s work when all other medicines

have failed

i believe that these astonishing results

are only the beginning the first wave of

cell therapies

and they give me hope when i think about

the number of patients

that i have operated on suffering from

brain cancer

like all tumors their condition starts

with a small number of brain cells

turning rogue

and these cells are extremely good at

escaping surgical tools

radiotherapy and chemotherapy

today there’s very little that we can

offer these patients despite

all the technical progress in

neurosurgery

their life expectancy is only about two

years my hope

is that car t and other cell therapies

will be similarly transformative for

these patients

or for example take the young boys

suffering from duchenne’s muscle

dystrophy

a horrible condition in which their

muscle cells

start to die due to imitation in a

specific

gene this leads to progressive muscle

weakness

and puts them into wheelchairs and the

condition progresses

until breathing becomes difficult what

their muscles need are healthy muscle

cells

again a problem that is best addressed

with cell

and gene therapy but so far there are

none

and what about the cell transplants for

parkinson’s

that have shown promising early effects

a decade and more ago

why is there still no treatment

why is it so difficult to get cell

therapies into the clinic

when it comes to cells there’s a

manufacturing crisis

cells are not easily accessible products

are inconsistent

and not scalable this is why today

there are only a handful of cell

therapies and why they cost

hundreds of thousands of dollars for a

single patient

the lack of a reliable source of human

cells also

holds back scientific discovery and the

development of more traditional drugs

to make cells available to everyone and

to treat

other conditions we need to manufacture

cells

at industrial scale so where do we get

cells for cell therapy

all cell types start as stem cells

which then go on to create all the cells

in our bodies

if you want to use cells for therapy you

can either take them

from people which is difficult and in

some cases not possible at all

or you can try and coax stem cells into

the right cell type

which after 20 years of research we know

is also very difficult

stem cell biologists study embryonic

development in order to obtain

cues of how stem cells can be turned

into the cell types required

for drug testing therapies and research

this approach has two problems it means

that you have to follow developmental

timelines

and these are long babies require nine

months until they’re born

and the approach is inconsistent because

it is based on stochastic events

in order to reach a particular cell type

stem cells have to undergo multiple

steps of differentiation

in which they produce slightly more

specific cells

this is a complex process

at each of these steps cells need to

make cell

fate choices they choose which cells

they actually produce

next and these choices are based on

chance events

during development this ensures that

really all cell types are generated

and the growing organism doesn’t miss a

cell or a tissue

or even an organ the particular cell

that we wanted to generate in my lab was

a human oligodendrocyte

these are support cells in the brain

that form insulating layers

around the processes of nerves they

facilitate rapid conduction of nerve

impulses

and provide nutrient support they are an

ideal cell for repairing

certain brain and spinal cord conditions

when we started out 10 years ago the

best protocol required more than 170

days of culture

during which we would feed and observe

the cells

change culture conditions add new

molecules

wait until the cell responded then again

change the media containing a new set of

molecules

and so on until we finally saw some

oligodendrocytes emerging

however we were never sure whether we

would actually be able to generate these

cells

and how many we’d be very happy if a

culture had

10 of cells

then i realized this is a common problem

in stem cell biology that nearly all of

us

working in this field were facing and

it’s an even bigger problem

if you want to manufacture cells at an

industrial scale

the inconsistency complexity and the

length of the protocols

means that they are very difficult to

scale so i had to look

for another way a radically new

perspective on biology

let’s just consider our current

situation

the reason why we’re not together in a

room is because the virus is hacking

into our cells to produce more virus

a virus is really little more than a

piece of genetic information

a program that contains a few genes

what can we learn from this does biology

run a sort of software

and if so can the same principles be

used to reprogram cells to another cell

type

in the 1980s when scientists first

figured out how to clone genes

harold weintraub identified a gene a

transcription factor

he called myod that when introduced into

other cells

turned them into muscle cell

unfortunately this piece of research was

long forgotten

harold died in early death from brain

cancer

in 2012 this concept that cells can be

reprogrammed has received renewed

attention

when shinya yamanaka and john garden

received the nobel prize for showing

that cells can be reprogrammed back into

stem cells

this is a true revolution because it

means that we can now

generate stem cells from every

individual and we don’t need to touch

any embryos

with all their ethical constraints

this inspired a handful of really

creative scientists

and amongst these marius wernick in

stanford to explore whether this concept

of celebrity probing

can be applied to other cell types

he showed that you can turn skin cells

into brain cells

and since then the field has taken off

and many more cell type programs

have been identified

however there was still a problem cell

reprogramming

relies on jump starting a new cell type

program

by the introduction of new genes in most

cases

scientists use a virus

in our lab we found that the cells

detect the genetic material introduced

by a virus

and that they do everything they can to

silence this new program

this means that the cells do not convert

so we had to design a different control

system

a hard problem i invested all my

resource

and the credibility of my group it was

really stressful

at the beginning of my scientific career

it took many years of work and the help

of multiple teams

and for the longest time we were only

making marginal improvements

until finally we designed a system that

relies on a direct intervention at the

dna

engineering a program into what are

called safe harbor sites of the cell

these are specialized areas in the dna

that are somehow protected

and they allow safe activation of genes

when we tested the system and activated

the first cell type program

encoding human brain cells i could not

believe my eyes

here you can see stem cells being

reprogrammed into brain cells

and what is remarkable is that every

stem cell in the culture seems to be

turning into a brain cell

at exactly the same time and once

they’ve reached a neuronal identity they

grow

processes that connect with each other

and form a neural network

and 10 days after initiating the program

the cells become

functional transmitting neural signals

this is one

order of magnitude faster than

traditional approaches

which often require 100 and more

the fact that all cells turned into

neurons was totally unexpected because

it went against

all the theories that certain cell

states were required to enable

reprogramming

in fact when we submitted our manuscript

for publication it first got rejected

because the reviewers did not believe

the data

and this is how it works all human cells

contain the same 20 000 genes which

cover

all genetic programs in a cell we

can call the entirety of these programs

the operating system of a cell

or life os at any given moment

only a subset of the genes a subset of

the genetic programs

is active in a cell the activity of

these programs is controlled by

transcription factors

like code words in a programming

language these

turn on networks of other transcription

factors and genes

and one to six of these transcription

factors encode the identity of the cell

every cell had its unique combination

and once you know that you can activate

it

and create a new cell type

our technology enables optimized over

expression of these transcription

factors in stem cells we call it optiox

it relies on engineering these code

words into the dna

so that they are not silenced and why is

the entire field thought

that for successful reprogramming cells

needed certain permissive states

our approach has proven that it is not

the case

and that all that is necessary for a

deterministic change in cell identity

is to control the activation of

transcription factors

this technology enables fast consistent

and scalable manufacturing of cells

it’s also truly a departure from biology

as we know it

and represents an approach to cells that

is much more like engineering

to leverage this opportunity and to

develop this technology

for the next generation of therapies i

became an entrepreneur

and i set up a company our mood shot

goal is to be able to

generate every cell in the body

and this is why it’s important having

access to a reliable and consistent

source of human cells is a game changer

a consistent source of human cells can

make scientific discovery more robust

this is a big problem in biology

experiments cannot be easily reproduced

and this has often to do with the

variability between the cells used for

experimentation

if scientists were able to include a

standardized set of cells in their

experiments in other words use the same

cells across the globe this would

greatly reduce this problem and it would

make experiments more interpretable in

order to develop a new drug

pharma companies screen millions of

chemicals and so far this has not been

possible in human cells

drugs are therefore developed using

animal models and cancer cell lines

however let’s take for example

alzheimer’s mice

don’t get alzheimer’s and cell lines

used for drug discovery

are very different from the brain cells

that the disease affects

so to generate better drugs and to do so

more efficiently

we need human cells that are actually

affected by alzheimer’s

and that can be used in high throughput

screens

finally what i’m most passionate about

are cell therapies

if we were able to manufacture the right

cells for the right conditions at scale

and perhaps even enhance their function

with the knowledge that we have gained

by understanding transcription factors

and the programs

they control we could generate new

intelligent

and curative medicines at a price point

where they become accessible to everyone

we could generate immune cells that are

able to dissolve

brain cancers or muscle cells that could

preserve the strength in boys suffering

from duchennes

and hopefully one day i will be able to

inject some cells into the spinal cords

of my patients

and perhaps connect them to electronic

devices

in order to make them walk again and

give them back

the use of their hands

you

[音乐]

嗨,

我的名字是马克,我是一名神经外科医生和

传感器生物学家

,在过去的 10 年里,我已经成为

一名企业家,

我想开始告诉你

我作为一名神经外科医生的工作,

我的重点是脊髓损伤

有人

在车祸中摔断了脖子

他们的脊髓很可能受损

创伤会破坏神经组织

神经细胞,它们的连接

以及周围的支持细胞

都会丢失,这可能导致立即瘫痪

和神经功能丧失

一位神经外科医生 在

患者到达急诊室

并通过影像确认受伤后,

我被叫到我的工作是

管理接下来的步骤

我的许多患者需要紧急

手术

我使用最先进的导航

系统来放置螺钉 像这样

进入脊髓周围的骨结构,

这可以稳定脊柱,但不能

修复神经

损伤脊髓无法

再生神经元 因受伤而失去联系的 lls

因此,我的大多数患者仍然处于

瘫痪状态,

无法用手或行走

,其中一些甚至无法

自主呼吸

。事实上,我

意识到我

作为神经外科医生所面临的许多情况 无论是

遗传性癌症还是退行性疾病,

都需要手术刀和螺丝钉之外的其他疾病,

而且它们也无法

用常规药物成功治疗,

因为它们需要再生

丢失的细胞

我们需要的是一场医学革命

一套新的复杂干预措施

这可以帮助解决这些最困难的

医学问题

我们需要从小分子和

生物制剂

转向新一代智能

治疗

药物 可以与环境相互作用的药物,也

就是细胞

疗法 细胞疗法已获

批准

基因工程免疫细胞

开始转变 癌症治疗

正如您在本视频中看到的,这些

所谓的 car t

细胞能够识别肿瘤细胞并

杀死它们

当所有其他药物都失败时,血癌车就起作用了

我相信这些惊人的结果

只是第一波

细胞疗法

的开始

所有肿瘤 他们的病情

始于少数脑细胞

变得

异常 这些细胞非常擅长

逃避手术工具

放射疗法和化学疗法

今天我们可以

为这些患者提供的服务很少 尽管

神经外科技术取得了所有进步

他们的预期寿命只有大约

两年后,我

希望 car t 和其他细胞疗法

对他们同样具有变革

性 患者

或例如

患有杜氏肌

营养不良症的年轻男孩

,这是一种可怕的状况,他们的

肌肉细胞

由于模仿特定基因而开始死亡,

这导致进行性肌肉

无力

并让他们坐在轮椅上,

病情进展

直到呼吸变得困难。 困难

他们的肌肉需要的是健康的肌肉

细胞

又是一个最好

用细胞

和基因疗法解决的问题,但到目前为止还

没有

,那么

帕金森氏症的细胞移植

在十年甚至更长时间前已经显示出有希望的早期效果,

为什么仍然存在 没有治疗

为什么细胞

疗法

很难进入临床 细胞存在

制造危机

细胞不容易获得

产品不一致

且不可扩展 这就是为什么今天

只有少数细胞

疗法以及它们为何昂贵

一个病人几十万美元

缺乏可靠的来源 人类

细胞还

阻碍了科学发现和

更传统药物的开发,

以使每个人都可以使用细胞

并治疗

我们需要以工业规模制造细胞的其他疾病

,因此我们从哪里获得

用于细胞治疗的细胞

所有细胞类型都从干细胞

开始 然后继续在我们体内制造所有细胞

如果您想使用细胞进行治疗,您

可以从人身上获取它们

,这很困难,在

某些情况下根本不可能,

或者您可以尝试将干细胞诱导

成正确的细胞类型

经过 20 年的研究,我们知道

这也是非常困难的

干细胞生物学家研究胚胎

发育以获得

关于如何将干细胞转化

为药物测试疗法和研究所需的细胞类型的线索

这种方法有两个问题,这

意味着你 必须遵循发育

时间表

,这些婴儿很长,需要 9

个月才能出生,

而且这种方法不一致,因为

它 是基于随机事件

,为了达到特定的细胞类型

干细胞必须经历多个

分化步骤,

在这些步骤中它们会产生稍微更

具体的细胞

这是

每个步骤的复杂过程细胞需要

做出细胞

命运选择

他们接下来实际生产的细胞

,这些选择是基于

发育过程中的偶然事件,这确保了

所有细胞类型都产生了

,并且正在生长的有机体不会错过

我们想要在其中产生的特定细胞的细胞或组织甚至器官 我的实验室是

一个人类少突胶质细胞,

它们是大脑中的支持细胞,在

神经过程周围形成绝缘层,它们

促进神经冲动的快速传导

并提供营养支持,当我们开始时,它们

是修复

某些大脑和脊髓状况的理想细胞

10 年前,

最好的方案需要 170 多

天的培养时间,

在此期间我们将喂食 并

观察细胞

改变培养条件添加新

分子

等到细胞反应然后再次

更换含有一组新

分子

的培养基等等直到我们最终看到一些

少突胶质细胞

出现但是我们不确定我们

是否真的能够产生这些

如果一个

培养物有

10 个细胞,我们会很高兴有多少个细胞,

然后我意识到这

是干细胞生物学中的一个常见问题,几乎

我们

在这个领域工作的所有人都面临着,如果你想的话,

这是一个更大的问题

工业

规模制造细胞 不一致的复杂性和

协议的长度

意味着它们很难

扩展,所以我不得不

寻找另一种方式 生物学的全新

视角

让我们考虑一下我们目前的

情况

是我们不这样做的原因 聚在一个

房间里是因为病毒正在

侵入我们的细胞以产生更多

病毒病毒实际上只不过是

一种遗传信息 离子

一个包含一些基因的程序

我们可以从中学到什么 生物学是否

运行某种软件

,如果可以的话,相同的原理可以用于在 1980 年代科学家们第一次想出如何克隆基因时使用相同的原理将

细胞重新编程为另一种细胞

类型

harold weintraub 发现了一种基因,一种

他称之为 myod 的转录因子,当它被引入

其他细胞时,

它们变成了肌肉细胞

当 Shinya yamanaka 和 john garden

证明细胞可以重新编程回

干细胞而获得诺贝尔奖时,

这是一场真正的革命,因为这

意味着我们现在可以

从每个人身上产生干细胞,

而且我们不需要接触

任何

胚胎 他们所有的道德约束

都激发了少数真正有

创造力的科学家

,其中包括马吕斯·韦尼克

斯坦福大学探索这种

名人探测的概念是否

可以应用于其他细胞类型,

他表明你可以将皮肤细胞

转化为脑细胞

,从那时起该领域已经起飞,

并且已经确定了更多的细胞类型程序,

但仍然存在问题 细胞

重编程

依赖于通过引入新基因来启动新的细胞类型

程序

在大多数

情况下

科学家

在我们的实验室中使用病毒 我们发现细胞

检测到由病毒引入的遗传物质

并且他们尽其所能来

沉默它 新程序

这意味着细胞不会转换

所以我们必须设计一个不同的控制

系统

一个难题 我投入了我所有的

资源

和我团队的信誉

在我的科学生涯开始时真的

很有压力 花了很多年的工作 以及

多个团队的帮助,

在很长一段时间内,我们只

进行了微小的改进,

直到最终我们设计了一个

依赖于 在 dna 的直接干预中,将

程序设计到

所谓的细胞安全港位点,

这些是 dna 中的特殊区域,

它们受到某种保护

当我们测试系统并

激活第一个细胞类型程序时,它们允许安全激活基因

编码人类脑细胞 我简直不敢

相信我的眼睛

在这里你可以看到干细胞被

重新编程为脑细胞

,值得注意的是培养物中的每个

干细胞似乎都

在完全相同的时间和一旦

它们变成脑细胞 已经达到神经元身份,它们会

生长

出相互连接

并形成神经网络的过程,

并且在启动程序 10 天后

,细胞开始

发挥功能,传递神经信号,

这比

通常需要 100 甚至更多

的传统方法快一个数量级事实 所有细胞都变成

神经元是完全出乎意料的,因为

它违背

了某些细胞的所有理论

事实上,当我们提交手稿出版时,州被要求启用重新编程,

它首先被拒绝,

因为审稿人不

相信数据

,这就是它的工作原理所有人类细胞

都包含相同的 20 000 个基因,这些基因

涵盖

了细胞中的所有遗传程序 我们

可以将所有这些程序

称为细胞的操作系统

或在任何给定时刻的生命操作系统

只有基因的一个子集 遗传程序的子集

在细胞中是活跃的

这些程序的活动由

诸如代码之类的转录因子控制 编程语言中的单词

这些

打开了其他转录

因子和基因的网络

,其中一到六个转录

因子编码了细胞的身份,

每个细胞都有其独特的组合

,一旦你知道你可以激活

并创造一种新的细胞类型

我们的技术可以优化

这些转录

因子在干细胞中的过度表达 我们称之为 optiox

它依赖于工程 这些密码

词进入 dna

以便它们不会被沉默,

为什么整个领域都

认为成功的重编程细胞

需要某些许可状态,

我们的方法已经证明事实

并非如此

,所有这些都是

确定性改变细胞所必需的 身份

是控制转录因子的激活

这项技术能够实现快速一致

和可扩展的细胞制造

它也真正背离

了我们所知道的生物学,

并且代表了一种细胞方法,

它更像

是利用这一机会并

开发这种细胞的工程

下一代疗法的技术 我

成为一名企业家

并成立了一家公司,我们的情绪

目标是能够

产生体内的每一个细胞

,这就是为什么

获得可靠且一致

的人体细胞来源很重要的原因 改变游戏规则

的人 一致的人体细胞来源可以

使科学发现更加强大

这是一个大专业 生物学

实验中的缺陷不能轻易复制

,这通常与

用于实验的细胞之间的变异性有关,

如果科学家能够

在他们的实验中包括一组标准化的细胞,

换句话说

,在全球范围内使用相同的细胞,这将

大大 减少这个问题,这

将使实验更具可解释性,

以便开发一种新的药物

制药公司筛选数百万种

化学物质,到目前为止,这

在人体细胞中是不可能的,

因此药物是使用

动物模型和癌细胞系开发的,

但是让我们举个例子

阿尔茨海默氏症的小鼠

不会感染阿尔茨海默氏症,

用于药物发现

的细胞系与该疾病影响的脑细胞非常不同,

因此为了产生更好的药物并更有效地做到这一点,

我们需要实际

受阿尔茨海默氏症影响的人类细胞

,这可以是 用于高通量

筛选

最终我最感兴趣的

是细胞疗法

如果我们能够

在合适的条件下大规模制造合适的细胞

,甚至可能

利用我们

通过了解转录因子

及其控制的程序

所获得的

知识

来增强它们的功能,我们就可以以

低于 每个人都可以使用它们

我们可以产生

能够溶解

脑癌的免疫细胞或肌肉细胞 可以

保持患有杜氏症的男孩的力量

希望有一天我能够

将一些细胞注射到

我的病人的脊髓

中 也许将它们连接到电子

设备

,以使它们再次行走并

让它们

重新使用双手